Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters

Cell Reports(2025)10.1016/j.celrep.2025.115907Source: DataRank Database

Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters is a research paper published in Cell Reports (2025). On theSindex it has a DataRank of 0. It has been cited 28 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access28 citations

Download PDF

Cite:

Linked data & code

geo gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 23.08)OA: goldTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Vicente Fajardo-Rosas,Esther Dawen Yu ORCID,Rosa Isela Gálvez ORCID,Adam Abawi,E. Alexandar Escarrega

Live enrichment

PubMed:40580476 PMC:PMC12695460 OpenAlex:https://openalex.org/W4411678001

National Institute of Allergy and Infectious Diseases Division of Intramural Research

Grant: 75N93019C00065

NIAID NIH HHS

Grant: U19 AI142742

NIAID NIH HHS

Grant: U19 AI118626

National Institute of Allergy and Infectious Diseases

National Institutes of Health

U.S. Department of Health and Human Services

FWCI

23.08

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by-sa

journalhttps://www.cell.com/action/showPdf?pii=S2211124725006783

publisherhttps://www.cell.com/action/showPdf?pii=S2211124725006783

publisherhttps://api.elsevier.com/content/article/PII:S2211124725006783?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124725006783?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2025.115907

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmune responses and vaccinations

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesAdultAgedAntibodies, ViralFemaleHumansImmunization, SecondaryImmunologic MemoryMaleMiddle AgedT-LymphocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesT-Lymphocytes, RegulatoryAdaptive ImmunitySingle-Cell AnalysisSpike Glycoprotein, Coronavirus

Keywords

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologySars virusBetacoronavirusCoronavirus InfectionsBiologyMedicineInfectious disease (medical specialty)Internal medicineOutbreakDiseaseantibody responsesExhaustionT Cell ResponsesBooster VaccinationAsymptomatic InfectionScrna-seqMrna VaccinesCovid-19Sars-cov-2Cp: Immunology